ALD-52 HCL

ALD-52, also known as 1-acetyl-LSD, is a chemical of lysergic acid diethylamide (LSD). It was originally discovered by Albert Hofmann but was not widely studied until the rise in popularity of psychedelics in the 1960s.

SKU: ALD-52 .HCL.POWDER Category:

Chemistry

ALD-52, or 1-Acetyl-N,N-diethyllysergamide, is a semisynthethic molecule of the Iysergamide chemical class. ALD-52 is a substituted derivative of lysergic acid. ALD-52’s structure contains four rings, a bicyclic hexahydroindole fused to a bicyclic quinoline group. This core structure of ALD-52 is an ergoline derivative, and has tryptamine and phenethylamine structures embedded within it. ALD-52 contains a N,N-diethylcarboxamide functional group bound to R8 of the chemical structure. It is additionally substituted at carbon 6 with a methyl group.

ALD-52 is homologous to 1P-LSD, which contains a propionyl group bound to CH3CO- instead of the acetyl group bound to the same location. It is unknown how these differences account for differences in the two compound’s activity.

Pharmacology

Further information: Serotonergic phychedelic

ALD-52 likely acts as a 5-HT2A partial agonist. The psychedelic effects are believed to come from ALD-52’s efficacy at the 5-HT2A receptors. ALD-52, alongside with 1P-LSD, is believed to act as a prodrug to LSD, though it is unclear as to whether it is capable of exerting its own effects.

Reports from many users suggest that the effects of ALD-52 are virtually identical to LSD. In comparison to other psychedelics such as psilocin, LSA and ayahuasca, ALD-52 is significantly more stimulating and fast-paced regarding the specific style of its physical and cognitive effects, as is the case with other lysergamides.

Disclaimer

ALD-52 .HCL.POWDER is for research use – Not for human or veterinary diagnostic or therapeutic use. It is the responsibility of the purchaser to determine suitability for other applications.

Reviews

There are no reviews yet.

Be the first to review “ALD-52 HCL”

Your email address will not be published. Required fields are marked *